USANA Health Sciences, Inc.
USNA
$16.87
-$0.27-1.58%
NYSE
| 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 226.20M | 213.67M | 235.85M | 249.54M | 213.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 226.20M | 213.67M | 235.85M | 249.54M | 213.61M |
| Cost of Revenue | 49.41M | 48.82M | 50.18M | 52.45M | 38.55M |
| Gross Profit | 176.79M | 164.86M | 185.66M | 197.09M | 175.06M |
| SG&A Expenses | 159.54M | 163.63M | 168.95M | 181.42M | 158.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 208.95M | 212.45M | 219.13M | 233.87M | 197.16M |
| Operating Income | 17.25M | 1.22M | 16.72M | 15.67M | 16.45M |
| Income Before Tax | 4.18M | 1.79M | 18.82M | 16.74M | 10.43M |
| Income Tax Expenses | 5.77M | 8.46M | 8.37M | 7.45M | 5.95M |
| Earnings from Continuing Operations | -1.60M | -6.66M | 10.44M | 9.29M | 4.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -180.00K | 140.00K | -789.00K | 112.00K | -30.00K |
| Net Income | -1.78M | -6.52M | 9.66M | 9.40M | 4.45M |
| EBIT | 17.25M | 1.22M | 16.72M | 15.67M | 16.45M |
| EBITDA | 25.81M | 9.14M | 24.46M | 24.01M | 20.45M |
| EPS Basic | -0.10 | -0.36 | 0.52 | 0.49 | 0.23 |
| Normalized Basic EPS | 0.59 | 0.07 | 0.59 | 0.56 | 0.61 |
| EPS Diluted | -0.10 | -0.36 | 0.52 | 0.49 | 0.23 |
| Normalized Diluted EPS | 0.59 | 0.07 | 0.59 | 0.55 | 0.61 |
| Average Basic Shares Outstanding | 18.30M | 18.29M | 18.51M | 19.05M | 19.10M |
| Average Diluted Shares Outstanding | 18.30M | 18.29M | 18.54M | 19.09M | 19.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |